The Tennessee Supreme Court ruled last week that defendants in the âSullivan Baby Doeâ and similar lawsuits can be sued for damages by infants harmed by their mothersâ use of opioids under the Tennessee Drug Dealer Liability Act. The court also ruled that district attorneys general who individually sued the pharmaceutical opioid companies on behalf of their districts did not have standing to sue under the DDLA. Prescription opioid manufacturers Endo Health Solutions Inc., Endo Pharmaceuticals Inc., and Teva Pharmaceuticals USA, Inc. remain as defendants in lawsuits filed by Tennessee district attorneys general. The âSullivan Baby Doeâ lawsuit, named for a baby born addicted to opiates in 2015 at Holston Valley Medical Center, was filed in June 2017. It spurred similar lawsuits filed by district attorneys general in other Tennessee counties, including a 2017 civil action filed by seven district attorneys general representing Campbell, Cocke and other counties referenced in the Supreme Court ruling.